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the manifestation of cognitive and physical impairment in stroke patients before the acute event 
suggests accumulating subclinical vascular pathology in the brain. We investigated whether 
impairments in cognitive and physical functioning were associated with an increased stroke risk. 
Between 2002 and 2008, 8,519 stroke-free non-demented participants from the population-based 
Rotterdam Study underwent cognition and physical assessments including Mini-Mental State 
Examination, 15-word learning test, Stroop test, letter-digit substitution test, verbal fluency test, 
purdue pegboard test and questionnaires on basic and instrumental activities of daily living (BADL; 
IADL). Principal component analysis was used to derive global cognition (G-factor). Incident stroke was 
assessed through continuous monitoring of medical records until 2016. Among 8,519 persons (mean 
age 66.0 years; 57.8% women), 489 suffered a stroke during mean follow-up of 8.7 years (SD: 2.9). 
Worse G-factor was associated with higher stroke risk (Hazard Ratio 1.21, 95% CI: 1.06–1.38), largely 
driven by unspecified stroke. Likewise, worse scores on 15-word learning test, Stroop test, Purdue 
pegboard test, IADL, and BADL were associated with higher risk of stroke. Thus both worse cognitive 
and physical functioning were associated with a higher stroke risk, in particular unspecified stroke and 
persons with worse memory, information processing, executive function, and motor function.
Stroke is a leading cause of disability and mortality worldwide and its burden is expected to rise due to aging pop-
ulations1,2. Post-stroke cognitive and physical deficits lead to dementia in one out of three stroke survivors and 
impairments in activities of daily living (ADL) in over half of the patients3,4. Besides post-stroke manifestations, 
cognitive deterioration was present in about 9–14% of the patients before their stroke and patients showed a faster 
decline in physical independency years prior to their stroke compared to stroke-free persons5,6.
Cognitive and physical deterioration are thus suggested to represent early manifestations of accumulating sub-
clinical vascular pathology in the brain prior to the acute event. Previous studies have indeed linked impairments 
in global cognitive and physical functioning with an increased risk of stroke5,7,8. Moreover, cognitive domains are 
indicated to be differentially affected by subclinical vascular pathology, with arteriolosclerotic damage thought 
to primarily affect executive domains and amyloid β being more related to memory9. Daily activities can also be 
divided into different domains including tasks that require mainly mobility, e.g. walking, and more cognitively 
challenging tasks, such as doing finances. However, earlier studies have generally relied on global markers of 
cognitive and physical functioning or used a limited number of tests that do not represent all domains5,10–12. 
Furthermore, ischemic pathology typically occurs due to arteriosclerotic and thrombotic processes, whilst the 
hemorrhagic component is affected by small vessel disease including amyloid β accumulation in the vessel wall13. 
Yet current literature does not differentiate between stroke subtypes.
We therefore investigated whether impairments in different domains of cognitive and physical functioning 
were associated with an increased risk of different stroke subtypes in community-dwelling individuals.
Methods
Study population. This study is embedded in the Rotterdam Study, an ongoing prospective popula-
tion-based cohort study in the Netherlands with the aim to investigate causes and determinants of diseases in 
elderly14. The cohort was initiated in 1990 and was expanded in 2000 and 2006, with a total of 14,926 participants 
aged 45 years or older. Baseline for the present study was formed by all participants from 2002 until 2008 (fourth 
visit of the first subcohort, second visit of the second subcohort and first visit of the third subcohort, n = 9,950), 
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when extensive cognitive assessment was introduced. We excluded participants who did not visit the research 
center during this period and thus did not undergo cognitive assessment, physical examinations and blood sam-
pling (n = 903), participants who refused informed consent for reviewing medical records for incident stroke, 
dementia or coronary heart disease (n = 233), and participants with prior stroke (n = 185) or prior dementia 
(n = 49). This resulted in a study population of 8,519 participants (Fig. 1).
The Rotterdam Study has been approved by the institutional review board (Medical Ethics Committee) of 
the Erasmus Medical Center and by the review board of the Netherlands Ministry of Health, Welfare and Sports. 
All participants provided written informed consent and all research was performed in accordance with relevant 
guidelines and regulations. The first author had full access to all the data in the study and takes responsibility for 
its integrity and the data analysis.
Assessment of cognition. During their visit to the research center, participants underwent routine cogni-
tive assessment, including the Mini-Mental State Examination (MMSE) and a battery of cognitive tests includ-
ing 15-word learning test (immediate recall, delayed recall, and recognition), Stroop test (reading, interference, 
and color naming task; error-adjusted time in seconds), letter-digit substitution test, verbal fluency test (animal 
categories), and Purdue pegboard test (both hands simultaneously)15. These tests tap into different cognitive 
domains, namely memory (15-word learning test), information processing (Stroop reading and color naming 
task, letter-digit substitution test), executive function (Stroop interference task, verbal fluency test) and fine 
motor function (Purdue pegboard test). The distribution of all tests was transformed into a normal standardized 
distribution and a Z-score for every individual was calculated. We used two different measurements for global 
cognition: the MMSE and the G-factor. The G-factor is a standardized compound score that is calculated using 
the principal component analysis. For tests with multiple subtasks, only one subtask was included in order to 
prevent highly correlated tasks distorting the factor loadings. The tests included were verbal fluency test, 15-word 
learning test (only delayed recall), letter-digit substitution test, Stroop test (only color naming task) and Purdue 
pegboard test. The G-factor explained 52.4% of the variance in our study population.
Assessment of physical functioning. Physical functioning was assessed with questionnaires on basic 
and instrumental activities of daily living (BADL and IADL). BADL was assessed with the disability index from 
the Stanford Health Assessment Questionnaire, which includes 20 items constituting eight components of phys-
ical activity: arising, dressing and grooming, hygiene, eating, walking, grip, reach, and activities16. Items were 
scored from 0–3 with higher scores indicating worse ability (0; no difficulty, 1; some difficulty, 2; much difficulty, 
3; unable to do). Component scores were calculated as the highest scored item in that component. BADL score 
was determined by summing all components, obtaining a score between 0 and 24. IADL was assessed with the 
Lawton and Brody Instrumental Activities of Daily Living scale17. This scale represents activities that require more 
cognitive capacity, and is divided into eight components: shopping, meal preparation, laundry, medication main-
tenance, management of finances, housekeeping, traveling alone and using a telephone. These items were scored 
likewise from 0 to 3 (from no difficulty to unable to do). IADL score was obtained by summing all components, 
resulting in a score between 0 and 24. If participants reported that they did not perform certain activities, these 
items were scored as non-applicable (15.6% of the IADL variables). To prevent selective loss of data, these items 
were imputed by the mean of five imputations, based on age, sex, all BADL items and all other available IADL 
items. Finally, both BADL and IADL scores were standardized into Z-scores with higher scores indicating higher 
independence.
Assessment of stroke. Stroke was defined according to the World Health Organization criteria as a syn-
drome of rapidly developing clinical signs of focal (or global) disturbance of cerebral function, with symptoms 
lasting 24 hours or longer or leading to death, with no apparent cause other than of vascular origin18. History 
of stroke at baseline was assessed during baseline interview and verified by reviewing medical records. After 
enrollment, participants were continuously monitored for incident stroke through automated linkage of the study 
database with files from general practitioners. Nursing home physicians’ and general practitioner’s files of partici-
pants who moved out of the district were checked on a regular basis as well. Additional information was obtained 
from hospital records. Potential strokes were reviewed by research physicians, and verified by an experienced 
stroke neurologist. Strokes were further classified as ischemic or hemorrhagic stroke based on neuroimaging 
reports or hospital discharge letters, and unspecified if these were absent. This classification corresponded with 
Figure 1. Flowchart of participants who met the inclusion/exclusion criteria. *Including participants of all 
subcohorts from 2002 until 2004 (fourth visit of the first subcohort, second visit of the second subcohort and 
first visit of the third subcohort).
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ICD-10 codes I61, I63 and I64. Participants could contribute person-years to the follow-up for a maximum of 
14 years, that is, from baseline until a first-ever stroke occurred, or until death, or, if lost to follow-up, until their 
last health status update when they were known to be free of stroke, whichever came first, or until January 2016. 
Follow-up was virtually complete (95.8%).
Assessment of dementia. The screening and follow-up for dementia has been extensively described 
elsewhere19. In short, participants were screened for dementia at baseline with the MMSE and the Geriatric 
Mental State Schedule (GMS). Screen-positives (MMSE < 26 or GMS > 0) underwent examination and informa-
tion review using the Cambridge Examination of Mental Disorders in the Elderly. A final dementia diagnosis was 
decided by a consensus panel led by an experienced neurologist. Participants were also continuously monitored 
for incident dementia through automated linkage of the study database with files from general practitioners and 
the regional institute for outpatient mental healthcare.
other measurements. Trained research physicians visited all participants at home for filling in standard-
ized questionnaires about health status, medication use and medical history. Body mass index (BMI) was calcu-
lated as weight (kg) divided by the square of height (m2). Blood pressure was measured at the right upper arm 
using a sphygmomanometer during two consecutive readings and the average of the two readings was used for 
further analysis. Blood samples were drawn to assess lipid and glucose levels, and apolipoprotein ε4 carriership. 
Diabetes mellitus type 2 was defined as a fasting glucose of ≥7.0 mmol/L, a non-fasting or post-load serum glu-
cose of ≥11.1 mmol/L, or blood glucose-lowering medication use. Smoking behavior was classified as current, 
past or never, and alcohol consumption was calculated in gram per day. Education was divided into primary, 
lower/intermediate education, intermediate vocational or higher general education, and higher vocational edu-
cation or university. To maximize our statistical power, missing data on covariates (except for apolipoprotein ε4 
carriership) was imputed using five-fold multiple imputation, based on determinants, outcome, and covariates. 
The percentage of missing values in covariates ranged from 0.4% to 3.4%.
Statistical analysis. Cox proportional–hazards models were used to estimate proportional hazard ratios 
of incidence stroke per unit decrease of baseline levels of cognitive and physical functioning. The proportional 
hazard assumption was met. Participants were censored at the time of any stroke in all initial analyses. In addi-
tion, we also performed a sub-analysis by additionally censoring for dementia. For analysis on the seven cog-
nitive tests separately, we determined the number of independent tests using the correlation matrix of these 
seven tests, which resulted in 6.3 independent tests. This value was used to calculate a Bonferroni corrected 
p-value threshold of p = 0.0079 (0.05/6.3). We adjusted for age and sex (model I) and additionally for systolic and 
diastolic blood pressure, blood pressure-lowering medication, total cholesterol, high-density lipoprotein choles-
terol, lipid-lowering medication use, BMI, diabetes mellitus type 2, smoking, alcohol use, level of education, and 
apolipoprotein ε4 carriership (model II). We furthermore estimated hazard ratios for stroke per unit decrease 
in cognitive and physical functioning after stratification for apolipoprotein ε4 carriership and sex. Finally, as a 
sensitivity analysis, we used validated cut-off points of baseline levels of MMSE, BADL and IADL and estimated 
Characteristic Descriptive
Age, mean (SD), years 66.0 (10.4)
Women, No. (%) 4,921 (57.8)
Body mass index, mean (SD), kg/m2 27.7 (4.3)
Systolic blood pressure, mean (SD), mm Hg 142.7 (22.1)
Diastolic blood pressure, mean (SD), mm Hg 81.0 (11.1)
Blood pressure-lowering drugs, No. (%) 3,156 (37.0)
Diabetes mellitus type 2, No. (%) 1,068 (12.5)
Total cholesterol, mean (SD), mmol/L 5.6 (1.0)
High-density lipoprotein, mean (SD), mmol/L 1.4 (0.4)
Lipid-lowering drugs, No. (%) 1,832 (21.5)
Smoking, No. (%)
   Current 1,650 (19.4)
   Former 4,291 (50.3)
   Never 2,578 (30.3)
Alcohol, mean (SD), g/day 10.6 (12.8)
Education, No. (%)
   Primary 942 (11.1)
   Low/intermediate 3,456 (40.6)
   Intermediate 2,490 (29.2)
   Higher 1,631 (19.1)
Apolipoprotein (ApoE) ε4 carrier* 2,302 (27.0)
Table 1. Baseline characteristics of the 8,519 participants. No = number; SD = standard deviation. *The 
apolipoprotein ε4 carriership measurement was missing in 314 participants (3.7%).
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the hazard ratios for stroke incidence in each group. All data analysis was performed using IBM SPSS version 21 
and R 3.4.0 software.
Results
Baseline characteristics of the study population are summarized in Table 1. Mean age of the 8,519 partic-
ipants was 66.0 years (SD: 10.4), of whom 57.8% were women. During a mean follow-up of 8.7 years (SD: 
2.9) a total of 489 strokes occurred, including 363 (74.2%) ischemic strokes, 62 (12.7%) hemorrhagic strokes 
and 64 (13.1%) unspecified strokes. Lower MMSE scores were not associated with a higher risk of any stroke 
(Table 2). However, lower G-factor at baseline showed a significant association with a higher risk of any stroke 
(per SD decrease HR 1.21, 95% CI: 1.06–1.38). Also, lower scores on both BADL and IADL were significantly 
associated with an increased risk of any stroke. These results did not differ across model I and II (model I 
not shown). After additional censoring for incident dementia, the association between G-factor and any 
stroke was attenuated whereas the associations between both ADL scores and any stroke remained present. 
Analysis on separate stroke subtypes revealed strong associations between G-factor and BADL score and risk 
of unspecified stroke (Table 3). BADL score was also significantly associated with the risk of ischemic stroke. 
After additional censoring for incident dementia the results remained stable and the association between 
IADL and the risk of unspecified stroke was strengthened and became significant. The analysis on separate 
cognitive tests showed that the 15-word learning test, all three Stroop subtasks, and the Purdue pegboard test 
were significantly associated with a higher risk of any stroke (Table 4). The Stroop interference task however 
did not survive multiple testing correction. Participants with lower scores on the Purdue pegboard test had 
the highest risk of stroke (per SD decrease HR 1.27, 95% CI: 1.13–1.44). Furthermore, all separate cognitive 
tests were significantly associated with a higher risk of unspecified stroke. Stratification for apolipoprotein ε4 
carriership showed strong associations between G-factor, BADL and IADL and the risk of unspecified stroke 
in participants who were apolipoprotein ε4 carriers. It also revealed an interaction in the association between 
G-factor and risk of unspecified stroke (p-value for interaction 0.044) (Table 5). Stratification for sex showed 
no interaction (data not shown). Furthermore, repeating the analysis with validated cut-off points for baseline 
levels of MMSE, BADL and IADL showed that patients beneath these thresholds, hence those with cognitive 
impairment and moderate to severe impairments in daily activities, had a higher risk of stroke than those 
without these impairments.(Supplementary Table S1). These hazard ratios were higher than those estimated 
in the per SD unit decrease analysis.
Discussion
In this prospective population-based cohort study, we found that worse cognitive and physical functioning were 
associated with a higher risk of stroke, in particular for the risk of unspecified stroke. With respect to specific 
cognitive domains, these associations were present in persons with poorer performance on memory, information 
processing, executive function, and motor function.
Any stroke
Any stroke (dementia 
censored)
Cognitive functioning
MMSE (per point decrease)
   n/N 476/8,194 437/8,194
   HR (95% CI) 1.03 (0.99–1.06) 1.01 (0.96–1.05)
G-factor (per SD decrease)
   n/N 359/6,907 331/6,907
   HR (95% CI) 1.21 (1.06–1.38) 1.13 (0.99–1.30)
Physical functioning
BADL (per SD decrease)
   n/N 455/7,312 417/7,312
   HR (95% CI) 1.18 (1.07–1.29) 1.20 (1.09–1.33)
IADL (per SD decrease)
   n/N 476/8,180 437/8,180
   HR (95% CI) 1.10 (1.01–1.19) 1.10 (1.01–1.20)
Table 2. Associations of cognitive and physical functioning with risk of stroke, additionally censored for 
incident dementia. BADL = Basic Activities of Daily Living; CI = confidence interval; HR = hazard ratio; 
IADL = Instrumental Activities of Daily Living; MMSE = Mini-Mental State Examination; SD = standard 
deviation. Higher scores on MMSE and G-factor indicate better cognitive function. Higher scores on ADL 
indicate higher independence. All analyses were censored for incident stroke (any stroke) and additionally for 
incident dementia. Significant associations are displayed in bold text. Model II is shown, results did not differ 
across model I and II. Adjusted for age, sex, systolic and diastolic blood pressure, blood pressure-lowering 
medication, total cholesterol, high-density lipoprotein cholesterol, lipid-lowering medication use, BMI, diabetes 
mellitus type 2, smoking, alcohol use, level of education and apolipoprotein e4 carriership.
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Previous studies showed that a lower score on MMSE or a comparable routine cognitive screening test was 
associated with an increased risk of stroke10–12,20,21. In our study, the G-factor showed a significant association 
with the risk of stroke and not the MMSE. An explanation could be that the MMSE, although commonly 
used in practice, is relatively insensitive for mild cognitive impairment and focuses mostly on orientation 
and memory22 whereas the G-factor is thought to be a more comprehensive summary of a person’s cognitive 
functioning.
Furthermore, we found similar associations with the risk of stroke across different cognitive domains that are 
thought to be linked to arteriolosclerotic and amyloid β accumulation, suggesting that both pathways underlie 
the pathophysiology of stroke. In the ARIC study, cognition was assessed through the Delayed Word Recall test, 
the Digit Symbol Subtest and the Word Fluency test, which underlie memory, psychomotor performance and 
linguistic impairment, respectively. In an initial analysis no association was found between cognitive impair-
ment and risk of stroke23. However, a subsequent analysis from the ARIC Study, that included all cardiovascular 
events (stroke, myocardial infarctions or coronary heart disease related death) did find a significant associa-
tion with lower scores on the cognitive tests, suggesting that the first study may have been underpowered24. The 
Framingham study used a battery of cognitive tests and had a study population similar to the present study25. 
Deficit in executive function was associated with an increased risk of stroke. The other cognitive tests suggested 
an association with stroke, but did not reach statistical significance.
Two large prospective studies on basic physical functioning, measured with questionnaires including walking, 
dressing and bathing, also found an association with physical dependence and risk of stroke5,26. However, these 
findings could not be replicated in another prospective study including 9,451 persons20. The BADL score and the 
Purdue pegboard test, both representing motor function, showed strong associations with the risk of stroke in 
our study. Impaired motor function may be a result of structural brain changes, as disability has previously been 
linked to an increased all-cause mortality risk27,28.
The IADL score, which includes more cognitively challenging tasks, was also associated with the risk of stroke. 
A previous study used general markers on the intellectual activity of persons, such as reading newspapers, and 
found a similar association with the risk of stroke7. The association with IADL was mostly attenuated after addi-
tional censoring for dementia, strengthening the suggestion that a low IADL score is partially a result of cognitive 
impairment.
Focusing on the risk of different stroke subtypes, the effect sizes were the largest for unspecified strokes. As 
mentioned before, we classified a stroke as unspecified when there was no neuroimaging conducted or available. 
In general, these unspecified stroke cases were those in which the general practitioners or the nursing home phy-
sicians did not refer the patient to the hospital, due to severe paresis or because participants were frailer with poor 
overall health due to extensive co-morbidities for which an elaborate evaluation in the hospital was not desirable. 
This may explain why we found the strongest associations in this subgroup.
An underlying pathophysiological mechanism for our findings could be that cognitive and physical impair-
ment share a common cause with stroke due to accumulating cerebral vascular pathology9,29,30. Pre-existent 
Ischemic stroke
Ischemic stroke 
(emented censored)
Hemorrhagic 
stroke
Hemorrhagic stroke 
(dementia censored)
Unspecified 
stroke
Unspecified 
stroke (dementia 
censored)
Cognitive functioning
MMSE (per point decrease)
   n/N 352/8,194 334/8,194 61/8,194 56/8,194 63/8,194 47/8,194
   HR (95% CI) 1.02 (0.98–1.07) 1.01 (0.96–1.06) 0.94 (0.81–1.08) 0.88 (0.75–1.03) 1.06 (0.98–1.15) 1.04 (0.94–1.15)
G-factor (per SD decrease)
   n/N 271/6,907 258/6,907 44/6,907 41/6,907 44/6,907 32/6,907
   HR (95% CI) 1.10 (0.94–1.28) 1.07 (0.91–1.26) 1.06 (0.72–1.58) 0.93 (0.61–1.43) 1.82 (1.39–2.38) 1.73 (1.24–2.42)
Physical functioning
BADL (per SD decrease)
   n/N 335/7,312 318/7,312 61/7,312 56/7,312 59/7,312 43/7,312
   HR (95% CI) 1.13 (1.01–1.26) 1.15 (1.02–1.29) 1.08 (0.82–1.42) 1.08 (0.81–1.44) 1.36 (1.09–1.69) 1.59 (1.24–2.03)
IADL (per SD decrease)
   n/N 353/8,180 335/8,180 61/8,180 56/8,180 62/8,180 46/8,180
   HR (95% CI) 1.04 (0.94–1.15) 1.03 (0.93–1.14) 1.11 (0.88–1.41) 1.14 (0.89–1.45) 1.20 (1.00–1.44) 1.33 (1.08–1.63)
Table 3. Associations of cognitive and physical functioning with risk of stroke subtype, additionally censored 
for incident dementia. BADL = Basic Activities of Daily Living; CI = confidence interval; HR = hazard ratio; 
IADL = Instrumental Activities of Daily Living; MMSE = Mini-Mental State Examination; SD = standard 
deviation. Higher scores on MMSE and G-factor indicate better cognitive function. Higher scores on ADL 
indicate higher independence. All analyses were censored for incident stroke (any stroke) and additionally for 
incident dementia. Significant associations are displayed in bold text. Model II is shown, results did not differ 
across model I and II. Adjusted for age, sex, systolic and diastolic blood pressure, blood pressure-lowering 
medication, total cholesterol, high-density lipoprotein cholesterol, lipid-lowering medication use, BMI, diabetes 
mellitus type 2, smoking, alcohol use, level of education and apolipoprotein e4 carriership.
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vascular risk factors result in cerebral small vessel disease such as lacunar infarcts and white matter hyperinten-
sities, which can lead to an increased risk of stroke and also to cognitive and physical impairment9,29. Cerebral 
small vessel disease and subsequently arterial stiffness are considered potential causes of cerebral hypoperfusion, 
which is associated with accelerated cognitive decline and increased risk of dementia30. Another explanation 
of our results could be through neurodegeneration. We showed that apolipoprotein ε4 carriers were at a much 
higher risk of unspecified stroke than non-carriers, implying that β-amyloid accumulation could underlie this 
association. This could again be through arterial stiffening and impaired vasodilatation that occur as a result of 
the β-amyloid deposition31. Additional censoring for incident dementia attenuated the association of G-factor 
with incident stroke risk, again suggesting an underlying neurodegenerative component. In contrast, the ADL 
scores and Purdue pegboard test results were not attenuated implicating that neurodegenerative processes seem 
to play a more limited role in their association with stroke.
Several limitations of this study need to be discussed: First, as not all participants performed all sub-tasks 
listed on the questionnaires on IADL, a total of 15.6% of these variables were missing. However, by imputing 
these data using the other covariates including the BADL scores, we prevented selective loss of data. Second, as is 
the case in other population-based studies, we had a relatively large number of unspecified stroke cases in which 
we could not determine the specific subtype due to lacking neuroimaging32. Strengths of our study include: The 
prospective design with an average follow-up of 8.7 years with nearly complete follow-up and the availability of 
extensive cognitive tests and questionnaires on both basic and instrumental ADL. The latter resulted in a reliable 
estimate of cognition and physical functioning per individual.
conclusions
We found that both worse cognitive and physical functioning were associated with a higher risk of stroke in the 
general population. Poorer performance on specific cognitive tests that reflect memory, information processing, 
executive function and motor function showed a similar association. Cognitive and physical testing could be a 
potential marker of pre-existing cerebrovascular pathology.
Cognitive test  
(per SD decrease) Any stroke Ischemic stroke
Hemorrhagic 
stroke
Unspecified 
stroke
Memory
15-Word learning test
   n/N 415/7,397 308/7,397 52/7,397 55/7,397
   HR (95% CI) 1.17 (1.04–1.32) 1.13 (0.99–1.31) 0.90 (0.63–1.29) 1.64 (1.21–2.23)
Information processing
Stroop reading task
   n/N 405/7,408 296/7,408 52/7,408 57/7,408
   HR (95% CI) 1.13 (1.04–1.23) 1.05 (0.93–1.18) 0.94 (0.69–1.28) 1.37 (1.22–1.55)
Stroop color naming task
   n/N 405/7,408 296/7,408 52/7,408 57/7,408
   HR (95% CI) 1.10 (1.05–1.16) 1.03 (0.91–1.16) 1.08 (0.87–1.35) 1.17 (1.10–1.24)
Letter-digit substitution test*
   n/N 438/7,889 328/7,889 58/7,889 52/7,889
   HR (95% CI) 1.08 (0.96–1.21) 1.02 (0.89–1.17) 0.93 (0.68–1.29) 1.72 (1.19–2.48)
Executive function
Stroop interference task
   n/N 402/7,394 296/7,394 52/7,394 54/7,394
   HR (95% CI) 1.10 (1.02–1.19)† 1.03 (0.93–1.15) 0.98 (0.74–1.28) 1.26 (1.14–1.41)
Verbal fluency test
   n/N 422/7,660 313/7,660 53/7,660 56/7,660
   HR (95% CI) 1.09 (0.97–1.22) 1.04 (0.91–1.18) 0.88 (0.64–1.21) 1.81 (1.30–2.52)
Motor function
Purdue pegboard test
   n/N 422/7,725 317/7,725 54/7,725 51/7,725
   HR (95% CI) 1.27 (1.13–1.44) 1.17 (1.02–1.35) 1.34 (0.95–1.88) 1.79 (1.28–2.48)
Table 4. Associations of separate cognitive tests with risk of stroke subtype. CI = confidence interval; 
HR = hazard ratio; SD = standard deviation. Higher scores on cognitive tests indicate better cognitive function. 
All analyses were censored for incident stroke (any stroke). Significant associations after correction for multiple 
testing are displayed in bold text. Model II is shown, results did not differ across model I and II. Adjusted for 
age, sex, systolic and diastolic blood pressure, blood pressure-lowering medication, total cholesterol, high-
density lipoprotein cholesterol, lipid-lowering medication use, BMI, diabetes mellitus type 2, smoking, alcohol 
use, level of education and apolipoprotein e4 carriership. *Some studies include the letter-digit substitution test 
in the executive function domain. †Associations with p < 0.05 that did not survive multiple testing correction.
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Data availability
Rotterdam Study data can be made available to interested researchers upon request. Requests can be directed to 
data manager Frank J.A. van Rooij (f.vanrooij@erasmusmc.nl). We are unable to place data in a public repository 
due to legal and ethical restraints. Sharing of individual participant data was not included in the informed consent 
of the study, and there is potential risk of revealing participants’ identities as it is not possible to completely 
anonymize the data. This is of particular concern given the sensitive personal nature of much of the data collected 
as part of the Rotterdam Study.
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